Axitinib for Renal Cell Carcinoma User Reviews
Brand names: Inlyta
- Quilly
- Taken for less than 1 month
- September 5, 2019
"So far axitinib is making me vomit more."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Renal Cell Carcinoma
Care guides
Symptoms and treatments
More about axitinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Inlyta (axitinib) "Husband is taking Inlyta now for @ 4 months. Visible tumors have reduced in size by almost half. Side effects that have shown up are Endocrine in nature: Adrenal glands reduced production, Feet Glands for corns and bone spurs, mucus membrane in sinus, loss of salivation production. Greater thirst is prevalent and additional fluid for intake to maintain hydration. Due to this, 2 additional pills introduced: Levothyroxine for Thyroid and Cortisone type (??name) for Adrenal gland function. Specialists now are: Oncologist, Endocrinologist, Podiatrist, Nephrologist (for the 1 remaining kidney), and his Primary Dr."